He JX - Search Results

1

Truncated analogues of endothelin and sarafotoxin are selective for the ETB receptor subtype.

Heyl DL, Cody WL, He JX, Flynn MA, Welch KM, Reynolds EE, Doherty AM. Heyl DL, et al. Among authors: he jx. Pept Res. 1993 Sep-Oct;6(5):238-41. Pept Res. 1993. PMID: 8257799

2

In vitro and in vivo studies with a series of hexapeptide endothelin antagonists.

Doherty AM, Cody WL, He JX, DePue PL, Cheng XM, Welch KM, Flynn MA, Reynolds EE, LaDouceur DM, Davis LS, et al. Doherty AM, et al. Among authors: he jx. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S98-102. doi: 10.1097/00005344-199322008-00027. J Cardiovasc Pharmacol. 1993. PMID: 7510009

3

Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.

Cody WL, He JX, DePue PL, Waite LA, Leonard DM, Sefler AM, Kaltenbronn JS, Haleen SJ, Walker DM, Flynn MA, et al. Cody WL, et al. Among authors: he jx. J Med Chem. 1995 Jul 21;38(15):2809-19. doi: 10.1021/jm00015a003. J Med Chem. 1995. PMID: 7636842

4

Pharmacological differences between rat and human endothelin B receptors.

Reynolds EE, Hwang O, Flynn MA, Welch KM, Cody WL, Steinbaugh B, He JX, Chung FZ, Doherty AM. Reynolds EE, et al. Among authors: he jx. Biochem Biophys Res Commun. 1995 Apr 17;209(2):506-12. doi: 10.1006/bbrc.1995.1530. Biochem Biophys Res Commun. 1995. PMID: 7733918

5

Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues.

Heyl DL, Sefler AM, He JX, Sawyer TK, Wustrow DJ, Akunne HC, Davis MD, Pugsley TA, Heffner TG, Corbin AE, et al. Heyl DL, et al. Among authors: he jx. Int J Pept Protein Res. 1994 Sep;44(3):233-8. doi: 10.1111/j.1399-3011.1994.tb00165.x. Int J Pept Protein Res. 1994. PMID: 7822099

6

Structure-activity relationships of C-terminal endothelin hexapeptide antagonists.

Doherty AM, Cody WL, DePue PL, He JX, Waite LA, Leonard DM, Leitz NL, Dudley DT, Rapundalo ST, Hingorani GP, et al. Doherty AM, et al. Among authors: he jx. J Med Chem. 1993 Sep 3;36(18):2585-94. doi: 10.1021/jm00070a001. J Med Chem. 1993. PMID: 8410970

7

In vitro assessment of oral delivery for hexapeptide endothelin antagonists.

Stewart BH, Reyner EL, Tse E, Hayes RN, Werness S, He JX, Cody WL, Doherty AM. Stewart BH, et al. Among authors: he jx. Life Sci. 1996;58(12):971-82. doi: 10.1016/0024-3205(96)00045-8. Life Sci. 1996. PMID: 8786709

8

Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.

Cody WL, He JX, Reily MD, Haleen SJ, Walker DM, Reyner EL, Stewart BH, Doherty AM. Cody WL, et al. Among authors: he jx. J Med Chem. 1997 Jul 4;40(14):2228-40. doi: 10.1021/jm970161m. J Med Chem. 1997. PMID: 9216842

9

Design of a functional hexapeptide antagonist of endothelin.

Cody WL, Doherty AM, He JX, DePue PL, Rapundalo ST, Hingorani GA, Major TC, Panek RL, Dudley DT, Haleen SJ, et al. Cody WL, et al. Among authors: he jx. J Med Chem. 1992 Aug 21;35(17):3301-3. doi: 10.1021/jm00095a029. J Med Chem. 1992. PMID: 1324321 No abstract available.

10

Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues.

Sefler AM, He JX, Sawyer TK, Holub KE, Omecinsky DO, Reily MD, Thanabal V, Akunne HC, Cody WL. Sefler AM, et al. Among authors: he jx. J Med Chem. 1995 Jan 20;38(2):249-57. doi: 10.1021/jm00002a006. J Med Chem. 1995. PMID: 7830267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

364 results

Search Page

Filters